This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page AWMP118-AWMP118, February 1, 2025. Background and Purpose:Thrombolysis can improve outcome in patients with acute ischemic stroke. Properties of the formed thrombus may influence thrombolysis efficiency and impede recanalization success.
Stroke, Volume 56, Issue Suppl_1 , Page AWP11-AWP11, February 1, 2025. Introduction:Stroke is a leading cause of disability and mortality worldwide, with thrombolysis as a critical treatment. Studies aiming to assess the outcomes of thrombolysis after ischemic stroke in LMIC were selected.
Stroke, Volume 56, Issue Suppl_1 , Page ATP25-ATP25, February 1, 2025. Background:Previous study found that compared with thrombolysis, antiplatelet did not improve outcomes but reduce the risk of symptomatic intracranial hemorrhage(sICH) for mild acute ischemic stroke(AIS) defined as National Institutes of Health Stroke Scale score 0 to 5.
Stroke, Volume 56, Issue Suppl_1 , Page AWP6-AWP6, February 1, 2025. Background and Purpose:Whether imaging markers of cerebral small vessel disease on computed tomography (CT-CSVD) relates to early clinical outcomes after intravenous thrombolysis for acute ischemic stroke remains not well understood. 1.95, p = 0.019).Conclusion:This
Stroke, Volume 56, Issue Suppl_1 , Page AWP3-AWP3, February 1, 2025. Introduction:Large vessel recanalization (LVR) is a well described phenomenon following intravenous thrombolysis (IVT). The secondary endpoint was 90-day modified Rankin Scale (mRS) outcomes. 0.63], p<0.001 and OR 0.21 [95%CI 0.09-0.52],
Stroke, Volume 56, Issue Suppl_1 , Page ATP19-ATP19, February 1, 2025. The primary efficacy outcome was good 3-month functional outcome, defined as a modified Rankin scale (mRS) 0-2. Secondary efficacy outcomes were excellent 3-month functional outcome (mRS 0-1) and arterial recanalization during transfer.
Stroke, Volume 56, Issue Suppl_1 , Page AWP256-AWP256, February 1, 2025. Introduction:In acute stroke patients who receive revascularization with endovascular thrombectomy (EVT) alone vs intravenous thrombolysis (IVT) followed by EVT, combination treatment has shown improved outcomes measured by the modified Rankin Scale (mRS).
Stroke, Volume 56, Issue Suppl_1 , Page ATP11-ATP11, February 1, 2025. Introduction:Current guidelines suggest using intravenous thrombolysis (IVT) for patients experiencing acute ischemic stroke within 4.5 The safety outcome was the rate of symptomatic intracranial hemorrhage (SICH).Results:We hours of symptom onset.
Stroke, Volume 56, Issue Suppl_1 , Page ADP3-ADP3, February 1, 2025. hour window, and reperfusion through thrombolysis has been shown to enhance functional outcomes in patients with salvageable brain tissue beyond this timeframe.Objective:The aim of this study is to assess the efficacy and safety of thrombolysis administered more than 4.5
Stroke, Volume 56, Issue Suppl_1 , Page ATP8-ATP8, February 1, 2025. A good clinical outcome (mRS 90day 2) was achieved by 61.4%. Introduction:Treatment of acute stroke has its clear rules and established standards. Improvement occurred in 70.5% of patients. Mortality was 15.9%. The incidence of intracerebral hemorrhage was 9.1%
Stroke, Volume 56, Issue Suppl_1 , Page A4-A4, February 1, 2025. Introduction:The tenecteplase versus standard of care for minor ischemic stroke with proven occlusion (TEMPO-2) trial showed that patients presenting with minor deficits up to 12 h do not benefit from intravenous thrombolysis. mg/kg) or non-thrombolytic standard of care.
Stroke, Volume 56, Issue Suppl_1 , Page AWP9-AWP9, February 1, 2025. The effectiveness and safety of intravenous thrombolysis (IVT) for acute ischemic stroke in these cases, particularly those involving large vessel occlusions, are debated. Background:Acute ischemic stroke can result from extracranial arterial dissection.
Stroke, Volume 56, Issue Suppl_1 , Page ADP1-ADP1, February 1, 2025. Whether intravenous thrombolysis (IVT) is safe and effective for acute ischemic stroke (AIS) patients with CAA is largely unknown.Methods:This was an explorative analysis of a nationwide database of hospitalizations in the United States. 4.16], p=0.001).
Stroke, Volume 56, Issue Suppl_1 , Page AWP253-AWP253, February 1, 2025. Background and Aims:Endovascular treatment (EVT) alone has been confirmed to be non-inferior to intravenous thrombolysis (IVT) followed with EVT in acute ischemic stroke (AIS) due to large-vessel occlusion of the anterior circulation.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP26-ATMP26, February 1, 2025. Introduction:Telestroke has the potential to revolutionize acute stroke treatment by improving access to optimal stroke care, including time-sensitive care such as thrombolysis. presented 4 hours of last known well, no contraindications to thrombolysis).
Stroke, Volume 56, Issue Suppl_1 , Page ATP259-ATP259, February 1, 2025. Despite successful reperfusion, many patients still have unfavorable outcomes even in the presence of favorable arterial collaterals. These patients were dichotomized into favorable (mRS 0-2) and unfavorable outcome (mRS 3-6) groups.
Stroke, Volume 56, Issue Suppl_1 , Page A2-A2, February 1, 2025. Conclusion:Our results indicate a beneficial impact of IVT on the clinical outcomes of EVT in AIS-LVO patients with LII regarding functional outcomes and early neurological improvement. More studies of larger sample sizes are needed to corroborate such results.
Stroke, Volume 56, Issue Suppl_1 , Page ATP87-ATP87, February 1, 2025. Background:Early prediction of functional outcome after rtPA helps clinicians in prognostic conversations with stroke patients and their families. modified Rankin Scale (mRS) at one month, classified into good (mRS 2) and poor (mRS 5) outcomes was noted.
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014499, January 1, 2025. BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This days;P=0.046).
Stroke, Volume 56, Issue Suppl_1 , Page AHUP17-AHUP17, February 1, 2025. Patients included in this study received either thrombolysis, thrombectomy, or both and were cared for at Methodist Hospital in Indianapolis, Indiana.Results:Between the years of 2019-2022, there were 2,815 ischemic stroke patients at Methodist Hospital.
Stroke, Volume 56, Issue 1 , Page 183-189, January 1, 2025. We assessed the correlation of these parameters with infarct expansion, hemorrhagic transformation, and poor outcomes, defined as modified Rankin Scale scores of 4 to 6, at 3 months.RESULTS:A total of 65 cases were analyzed. Cerebral blood flow <45% (r=0.57;P<0.001)
Stroke, Volume 56, Issue Suppl_1 , Page ATP190-ATP190, February 1, 2025. We aimed to determine the relationship between the affected hemisphere (right or left) and differences in non-motor outcomes (pain, mood) in patients with acute intracerebral hemorrhage (ICH).
Stroke, Volume 56, Issue Suppl_1 , Page AHUP1-AHUP1, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and stroke outcomes remains elusive. Variables were derived from BASIC, Redfin and the National Neighborhood Data Archive (NaNDA).
Stroke, Volume 56, Issue Suppl_1 , Page ADP53-ADP53, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and stroke outcomes remains elusive. Variables were derived from BASIC, Redfin and the National Neighborhood Data Archive (NaNDA).
Stroke, Volume 56, Issue Suppl_1 , Page ATMP91-ATMP91, February 1, 2025. Demographic, clinical, radiographic, treatment and outcome data were collected via chart review and entered into a secure, HIPAA-compliant RedCAP database. Stroke presentation, treatment and outcomes are shown in Table 2.
Stroke, Volume 56, Issue Suppl_1 , Page AWP246-AWP246, February 1, 2025. This study aims to elucidate the outcomes and factors contributing to achieving excellent recanalization (mTICI 2c-3) versus successful recanalization (mTICI 2b) in MeVO stroke patients undergoing mechanical thrombectomy (MT).Methods:We
Stroke, Volume 56, Issue Suppl_1 , Page ATP24-ATP24, February 1, 2025. Introduction:Mobile Stroke Units (MSUs) are proven to shorten the time between stroke recognition and thrombolysis resulting to better patient outcomes and are deemed safe and cost-effective.
Stroke, Volume 56, Issue Suppl_1 , Page A13-A13, February 1, 2025. The primary efficacy outcome was favorable functional outcome, defined as modified Rankin Scale (mRS) scores of 0-3 at one year. The patients were divided into two groups based on whether they received adjunctive intravenous Tirofiban therapy or not.
Stroke, Volume 56, Issue Suppl_1 , Page ADP5-ADP5, February 1, 2025. Introduction:Outcomes after thrombolysis with alteplase (tPA) versus tenecteplase (TNK) prior to endovascular thrombectomy (EVT) have not been directly compared in real-world data (RWD). The rate of good functional outcomes was 35.1% The rate of ENI was 50.0%
Stroke, Volume 56, Issue Suppl_1 , Page AWP139-AWP139, February 1, 2025. Background:Telestroke allows rapid assessment of patients presenting with acute stroke symptoms for intravenous thrombolysis or endovascular thrombectomy (EVT). vs 3.1%), a lower rate for good functional outcome at 90-days (35.6%
Stroke, Volume 56, Issue Suppl_1 , Page AWMP53-AWMP53, February 1, 2025. Background:Treatment options and outcomes in stroke also depends on pre-hospital delays. Compared to the patients who reached by non-EMS mode, patients who reached by EMS mode were more likely to receive intravenous thrombolysis (16% vs 44%,).
Stroke, Volume 56, Issue Suppl_1 , Page AWP72-AWP72, February 1, 2025. The transition from Alteplase to Tenecteplase for AIS patients eligible for thrombolysis occurred on June 6, 2022. EHR Alteplase references were changed to thrombolysis. The percentage of door to thrombolysis<30 minutes improved from 23.3%
Stroke, Volume 56, Issue Suppl_1 , Page ATP84-ATP84, February 1, 2025. We gathered data on the availability of critical resources like thrombolysis, computerized tomography (CT), and neurology services at over 200 facilities. In the U.S., In the U.S.,
Stroke, Volume 56, Issue Suppl_1 , Page ATMP46-ATMP46, February 1, 2025. Background:The modified Rankin Scale (mRS) is a key measure of functional outcomes in stroke trials. The primary outcome, the 90-day mRS score, was gathered through in-person video recordings by blinded local personnel. 0.95) for remote audio.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP5-AWMP5, February 1, 2025. Several methods have been described to derive NNT for ordinal outcomes. Overall, the magnitude of treatment effect estimates rendered by Permutation methods were substantially lower than by Joint Outcome methods Table methods.
Stroke, Volume 56, Issue Suppl_1 , Page AWP245-AWP245, February 1, 2025. However, intravenous thrombolysis was performed more frequently in the non-user group than in the heparin group, and the apTT value after the procedure was higher in the heparin group than in the other groups(75.912.5 vs 21.3%, p=0.04).
Stroke, Volume 56, Issue Suppl_1 , Page ATP129-ATP129, February 1, 2025. As such, patient factors associated with delays in care can influence outcomes after MT and lead to health inequities. Introduction:An equitable health system requires access to clinical advances across society. hours versus 8.1
Stroke, Volume 56, Issue Suppl_1 , Page AWMP95-AWMP95, February 1, 2025. In light of context we aim in this investigation to assess the outcomes of these treatments.Methods:This multinational, multicenter study analyzed data from the Multicenter Analysis of Distal Medium Vessel Occlusions: Effect of Mechanical Thrombectomy (MAD-MT) registry.
Stroke, Volume 56, Issue Suppl_1 , Page AWP248-AWP248, February 1, 2025. Introduction:Endovascular thrombectomy (EVT) is effective in treating acute ischemic stroke, with research showing improved functional outcomes compared to medical treatment alone. Safety outcomes included ICH and 90 days mortality.
Stroke, Volume 56, Issue Suppl_1 , Page A127-A127, February 1, 2025. Primary outcome: door to needle (DTN) time of the APP versus neurology residents using quantile (median) regression adjusted for age, NIHSS and delays for treating hypertension. Patients treated greater than 4.5
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content